Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17815
Corporate User License Price USD 750
Corporate User License Price INR 53445
Site License Price USD 500
Site License Price INR 35630
Request a Quote

Report Title

Acer Therapeutics Inc (ACER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Acer Therapeutics Inc (ACER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Acer Therapeutics Inc (ACER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Acer Therapeutics Inc (ACER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Acer Therapeutics Inc (Acer), formerly Opexa Therapeutics Inc is a pharmaceutical company that offers acquisition, development and commercialization of therapies for patients with serious rare diseases. The company offers treatment of autoimmune disorders, rheumatoid arthritis, diabetes and heart failure. Its late-stage clinical pipeline includes drug candidates for severe genetic disorders such as EDSIVO and celiprolol for vascular Ehlers-Danlos syndrome, and ACER-001, a fully taste-masked, immediate release formulation of sodium phenylbutyrate for urea cycle disorders. It uses T-cell technology platform for the development of patient-specific T-cell therapies. The company operates manufacturing facility, and research and development facilities in the US and Canada. Acer is headquartered in Newton, Massachusetts, the US.

Acer Therapeutics Inc (ACER)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Acer Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Acer Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Acer Therapeutics Raises USD15.7 Million in Venture Financing 12

Acer Therapeutics to Raise USD10 Million in Venture Financing 13

Acer Therapeutics Raises USD8.2 Million in Financing 14

Acer Therapeutics Raises USD2 Million in Venture Financing 15

Licensing Agreements 16

Acer Therapeutics Enters into Licensing Agreement with AP-HP 16

Acer Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 17

Equity Offering 18

Acer Therapeutics Raises USD46 Million in Public Offering of Shares 18

Acer Therapeutics Completes Underwriters Partial Exercise of Over-Allotment of Public Offering of Shares for USD12.6 Million 20

Opexa Therapeutics Plans to Raise Funds through Public Offering of Shares 22

Opexa Therapeutics Raises USD0.5 Million in First Tranche of Private Placement of Shares 23

Opexa Therapeutics Raises USD13.8 Million in Rights Offering of Units 25

Opexa Therapeutics Completes Public Offering Of Shares For USD 8 Million 27

Opexa Therapeutics Completes Underwriters' Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For USD 19 Million 29

Opexa Therapeutics Completes Private Placement Of Shares For USD 0.5 Million 30

Opexa Therapeutics Completes Private Placement Of Units For USD 3.2 Million 31

Opexa Therapeutics Private Placement Of Common Stock For USD 0.5 Million 33

Opexa Therapeutics Files Prospectus For Public Offering Of Shares 34

Opexa Therapeutics Completes First Tranche Of Private Placement Of Shares For USD 0.05 Million 35

Debt Offering 37

Opexa Therapeutics Raises USD4.1 Million in Private Placement of Notes 37

Acquisition 38

Opexa Therapeutics Acquires Acer Therapeutics in Reverse Takeover Transaction 38

Acer Therapeutics Inc-Key Competitors 39

Acer Therapeutics Inc-Key Employees 40

Acer Therapeutics Inc-Locations And Subsidiaries 41

Head Office 41

Recent Developments 42

Financial Announcements 42

Aug 13, 2018: Acer Therapeutics reports second quarter 2018 financial results and provides corporate update 42

May 14, 2018: Acer Therapeutics Announces First Quarter 2018 Financial Results 44

Mar 07, 2018: Acer Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update 45

Nov 13, 2017: Acer Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update 47

Corporate Communications 48

Oct 12, 2017: Acer Therapeutics Welcomes Two New Members to its Board of Directors 48

Oct 05, 2017: Acer Therapeutics Appoints Dr. William T. Andrews as Chief Medical Officer 49

Product Approvals 50

Sep 25, 2017: Acer Therapeutics Reports Positive Results From Pivotal Clinical Trial of EDSIVO (celiprolol) for Treatment of Vascular Ehlers-Danlos Syndrome 50

Appendix 51

Methodology 51

About GlobalData 51

Contact Us 51

Disclaimer 51

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Acer Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Acer Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Acer Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Acer Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

Acer Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Acer Therapeutics Raises USD15.7 Million in Venture Financing 12

Acer Therapeutics to Raise USD10 Million in Venture Financing 13

Acer Therapeutics Raises USD8.2 Million in Financing 14

Acer Therapeutics Raises USD2 Million in Venture Financing 15

Acer Therapeutics Enters into Licensing Agreement with AP-HP 16

Acer Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 17

Acer Therapeutics Raises USD46 Million in Public Offering of Shares 18

Acer Therapeutics Completes Underwriters Partial Exercise of Over-Allotment of Public Offering of Shares for USD12.6 Million 20

Opexa Therapeutics Plans to Raise Funds through Public Offering of Shares 22

Opexa Therapeutics Raises USD0.5 Million in First Tranche of Private Placement of Shares 23

Opexa Therapeutics Raises USD13.8 Million in Rights Offering of Units 25

Opexa Therapeutics Completes Public Offering Of Shares For USD 8 Million 27

Opexa Therapeutics Completes Underwriters' Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For USD 19 Million 29

Opexa Therapeutics Completes Private Placement Of Shares For USD 0.5 Million 30

Opexa Therapeutics Completes Private Placement Of Units For USD 3.2 Million 31

Opexa Therapeutics Private Placement Of Common Stock For USD 0.5 Million 33

Opexa Therapeutics Files Prospectus For Public Offering Of Shares 34

Opexa Therapeutics Completes First Tranche Of Private Placement Of Shares For USD 0.05 Million 35

Opexa Therapeutics Raises USD4.1 Million in Private Placement of Notes 37

Opexa Therapeutics Acquires Acer Therapeutics in Reverse Takeover Transaction 38

Acer Therapeutics Inc, Key Competitors 39

Acer Therapeutics Inc, Key Employees 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Acer Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person